Wilms' tumor Recruiting Phase 2 Trials for DB00853 (Temozolomide)

Also known as: Wilms Tumour / Wilms Tumor / Wilm's Tumor / Wilm's tumour / Nephroma / Nephroblastoma

IndicationStatusPhase
DBCOND0021654 (Wilms' tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02689336Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsTreatment